1088 related articles for article (PubMed ID: 11279727)
21. Donepezil for mild and moderate Alzheimer's disease.
Birks J S; Melzer D
Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
[TBL] [Abstract][Full Text] [Related]
22. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Li Y; Hai S; Zhou Y; Dong BR
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
[TBL] [Abstract][Full Text] [Related]
23. Hydergine for dementia.
Olin J; Schneider L; Novit A; Luczak S
Cochrane Database Syst Rev; 2000; 2000(2):CD000359. PubMed ID: 10796534
[TBL] [Abstract][Full Text] [Related]
24. Physostigmine for Alzheimer's disease.
Coelho F; Birks J
Cochrane Database Syst Rev; 2001; 2001(2):CD001499. PubMed ID: 11405996
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
Fioravanti M; Flicker L
Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
[TBL] [Abstract][Full Text] [Related]
26. Tacrine for Alzheimer's disease.
Qizilbash N; Birks J; López-Arrieta J; Lewington S; Szeto S
Cochrane Database Syst Rev; 2000; 1999(2):CD000202. PubMed ID: 10796507
[TBL] [Abstract][Full Text] [Related]
27. Huperzine A for Alzheimer's disease.
Li J; Wu HM; Zhou RL; Liu GJ; Dong BR
Cochrane Database Syst Rev; 2008 Apr; (2):CD005592. PubMed ID: 18425924
[TBL] [Abstract][Full Text] [Related]
28. Rivastigmine for Alzheimer's disease.
Birks J; Grimley Evans J ; Iakovidou V; Tsolaki M
Cochrane Database Syst Rev; 2000; (4):CD001191. PubMed ID: 11034705
[TBL] [Abstract][Full Text] [Related]
29. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
30. Donepezil for mild and moderate Alzheimer's disease.
Birks JS; Melzer D; Beppu H
Cochrane Database Syst Rev; 2000; (4):CD001190. PubMed ID: 11034704
[TBL] [Abstract][Full Text] [Related]
31. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.
Rockwood K; Mintzer J; Truyen L; Wessel T; Wilkinson D
J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):589-95. PubMed ID: 11606667
[TBL] [Abstract][Full Text] [Related]
32. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.
Erkinjuntti T; Kurz A; Small GW; Bullock R; Lilienfeld S; Damaraju CV;
Clin Ther; 2003 Jun; 25(6):1765-82. PubMed ID: 12860497
[TBL] [Abstract][Full Text] [Related]
33. Rivastigmine for Alzheimer's disease.
Birks J; Iakovidou V; Tsolaki M
Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
[TBL] [Abstract][Full Text] [Related]
34. Rivastigmine for Alzheimer's disease.
Birks JS; Chong LY; Grimley Evans J
Cochrane Database Syst Rev; 2015 Sep; 9(9):CD001191. PubMed ID: 26393402
[TBL] [Abstract][Full Text] [Related]
35. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
36. Velnacrine for Alzheimer's disease.
Birks J; Wilcock GG
Cochrane Database Syst Rev; 2004; (2):CD004748. PubMed ID: 15106259
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of galantamine treatment for patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
Jiang D; Yang X; Li M; Wang Y; Wang Y
J Neural Transm (Vienna); 2015 Aug; 122(8):1157-66. PubMed ID: 25547862
[TBL] [Abstract][Full Text] [Related]
38. Tacrine for Alzheimer's disease.
Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
Cochrane Database Syst Rev; 2000; (3):CD000202. PubMed ID: 10908463
[TBL] [Abstract][Full Text] [Related]
39. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]